Developing a risk assessment score for cancer patients during COVID-19 pandemic

The novel coronavirus (CoV) pandemic is a serious threat for cancer patients, who have an immunocompromised status, and are considered at high risk for infections. Data on the novel CoV respiratory disease (COVID-19) in cancer patients are still limited. Unlike other common viruses, CoV have not shown to cause a more severe disease in immunocompromised subjects. Along with direct viral pathogenicity, in some individuals CoV infection triggers an uncontrolled aberrant inflammatory response, leading to lung tissue damage.

Source: European Journal of Cancer - May 30, 2020 Category: Cancer & Oncology Authors: Alice Indini, Erika Rijavec, Michele Ghidini, Monica Cattaneo, Francesco Grossi Tags: Original Research Source Type: research